Detecting Postoperative Recurrence in Crohn's Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00886327|
Recruitment Status : Unknown
Verified April 2009 by Johann Wolfgang Goethe University Hospital.
Recruitment status was: Recruiting
First Posted : April 22, 2009
Last Update Posted : May 31, 2012
Up to ¾ of patients who have been diagnosed with Crohn's disease (CD) will have to undergo bowel resection during their lifetime despite modern medical therapies. Unfortunately, disease recurrence is common and endoscopic detection of recurring inflammation precedes clinical relapse. Endoscopic investigation is therefore recommended to manage these patients.
This multi center, prospective study compares the conventional endoscopic method, ileo-colonoscopy to a new technique, i.e., colonic capsule endoscopy (CCE). CCE enables investigation of the small bowel and the large intestines by using a double-sided video camera with about 10 hours acquisition time.
This study aims to evaluate the performance of CCE to detect postoperative recurrence of CD and detection rate of colonic and anastomotic recurrence is compared to ileo-colonoscopy. Proximal (small bowel) lesions are additionally recorded and impact on clinical management of the findings is accounted for. Moreover, safety aspects and influence of the findings on progress of the disease are monitored. All consecutive patients who are operated for CD in any of the participating study centers are eligible. Included are patients with segmental small bowel, ileocecal or segmental colonic resection.
In some cases capsule retention has been reported at an average of 2-3% with CD patients at elevated risk. Therefore, patency capsule is performed before application of the video CCE to exclude bowel obstruction.
Sample size estimation results in n = 70, requiring each 140 capsule endoscopes and 140 patency capsules for performance of postoperative screening (ca 4-8 weeks postoperatively) and detection of postoperative recurrence (ca 4-8 months postoperatively).
|Condition or disease||Intervention/treatment|
|Crohn's Disease||Procedure: Colonic capsule endoscopy|
|Study Type :||Observational|
|Estimated Enrollment :||70 participants|
|Official Title:||Detection of Postoperative Recurrence of Crohn's Disease by Colonic Capsule-Endoscopy|
|Study Start Date :||May 2009|
|Estimated Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||December 2013|
Patients with CD who recently underwent bowel resection
Procedure: Colonic capsule endoscopy
- Detection of postoperative recurrence of CD
- Therapeutic intervention due to detection of recurrent CD
- Detection of small bowel lesions by CCE
- Rate of bowel stenosis as detected by PC
- Side effect of CCE and/or colonoscopy
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00886327
|Contact: Joerg G Albert, MD||+49696301 ext email@example.com|
|Klinikum der JW Goethe Universität Frankfurt||Recruiting|
|Frankfurt am Main, Germany|
|Contact: Joerg Albert, MD firstname.lastname@example.org|
|Medizinische Hochschule Hannover||Not yet recruiting|
|Universitaetsklnikum Leipzig||Not yet recruiting|
|Klinikum der Universität München - Campus Grosshadern||Not yet recruiting|
|Principal Investigator:||Joerg G Albert, MD||Johann Wolfgang Goethe University Hospital|